For the Inventor, By the Inventor

Enter inventor name

Draper, UT, United States of America

Hariprasad Vankayalapati

USPTO Granted Patents = 50 (Patent Applications = 14)

CIPO Patents = 4 (Patent Applications = 4)

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 350(Granted Patents)

Forward Citations (Not Self Cited) = 323(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Salt Lake City, UT (US) (2007 - 2021)
Draper, UT (US) (2010 - 2022)

Company Filing History:

Arrien Pharmaceuticals LLC

13 out of 1,650

University of Utah Research Foundation

4. 6 out of 973

The University of Arizona

Convergene, LLC

Montigen Pharmaceuticals, Inc.

Stingray Therapeutics, Inc.

Astex Pharmaceuticals, Inc.

Tolero Pharmaceuticals, Inc.

Beta Cat Pharmaceuticals, Inc.

Astex Pharmaceutials, Inc.

12. 1 out of 11

Sumitomo Dainippon Pharma Oncology, Inc.

14. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2022

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Quinoline Compounds

Ectonucleotide Pyrophosphatase

Cancer Immunotherapeutics

Bromodomain Inhibitors

Protein Kinase Inhibitors

Histone Demethylase Inhibitors

Tyrosine Receptor Kinase

Axl Kinase Inhibitors

Retinoic Acid Antagonists

JAK Kinase Inhibitors

Pyrimidine Derivatives

Imidazo Compounds

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11407729 - Quinoline and quinazoline compounds and methods of use thereof (2022-08-09),

2. 11142524 - Substituted-3H-imidazo[4,5-c]pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel Ectonucleotide Pyrophosphatase/Phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2021-10-12),

3. 11053221 - Substituted pyrimidines for inhibiting embryonic leucine zipper kinase activity (2021-07-06),

4. 10849901 - Arf6 inhibitors and methods of synthesis and use thereof (2020-12-01),

5. 10752594 - JAK1 and ALK2 inhibitors and methods for their use (2020-08-25),

6. 10717739 - Methods and compositions for inhibition of bromodomain-containing proteins (2020-07-21),

7. 10689376 - Substituted-3H-imidazo [4,5-c] pyridine and 1H-pyrrolo[2,3-c]pyridine series of novel ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) and stimulator for interferon genes (STING) modulators as cancer immunotherapeutics (2020-06-23),

8. 10682358 - Substituted 2, 3-dihydro-1H-inden-1-one retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis (2020-06-16),

9. 10266536 - Methods and compositions for inhibition of bromodomain-containing proteins (2019-04-23),

10. 10202356 - JAK2 and ALK2 inhibitors and methods for their use (2019-02-12),

11. 10172866 - Substituted 2,3-dihydro-1H-inden-1-one Retinoic acid-related orphan nuclear receptor antagonists for treating multiple sclerosis (2019-01-08),

12. 9963475 - Anthracene-9, 10-dione dioxime compound prodrugs and their uses (2018-05-08),

13. 9962382 - Substituted 5-(pyrazin-2-yl)-1H-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors (2018-05-08),

14. 9951062 - Substituted 1 H-pyrrolo [2, 3-b] pyridine and 1 H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors (2018-04-24),

15. 9890153 - Substituted 1H-pyrrolo [2, 3-b] pyridine and 1H-pyrazolo [3, 4-b] pyridine derivatives as salt inducible kinase 2 (SIK2) inhibitors (2018-02-13),

Title: Hariprasad Vankayalapati - Innovator from Draper, UT

Introduction:

Hariprasad Vankayalapati is a renowned inventor based in Draper, Utah. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to the field of technology.

Latest Patents:

Hariprasad Vankayalapati holds several patents in various technological domains, showcasing his versatility and creativity in inventing novel solutions to complex problems.

Career Highlights:

Throughout his career, Hariprasad Vankayalapati has worked tirelessly to bring his innovative ideas to life. His dedication to pushing the boundaries of technology has led to the development of groundbreaking inventions that have made a lasting impact on the industry.

Collaborations:

Hariprasad Vankayalapati has collaborated with leading tech companies and research institutions to further his inventions and bring them to the market. His ability to work effectively in teams has been instrumental in the success of many projects.

Conclusion:

In conclusion, Hariprasad Vankayalapati is a visionary inventor whose passion for innovation has driven him to create groundbreaking solutions to complex problems. His contributions to the field of technology have solidified his reputation as a leading innovator in the industry.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…